Biopump for the treatment of Hepatitis D has received orphan drug status from the US Food and Drug Administration (FDA). Medgenics Biopump technology platform, which produces interferon alpha, commonly used to treat hepatitis. Medgenics said that this is the first orphan drug status granted for...
FULL ARTICLE AT Globes Online